Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/06/22 20:45:57」(JST)

wiki en

Sulfadoxine (also spelled sulphadoxine) is an ultra-long-lasting sulfonamide previously used in combination with pyrimethamine to treat or prevent malaria.^[1] Due to high levels of resistance, its use is no longer recommended routinely.^[2] It is also used, usually in combination with other drugs, to treat or prevent various infections in livestock.^[3]

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.^[4]

Mechanism of action

Sulfadoxine competitively inhibits dihydropteroate synthase, interfering with folate synthesis.

Synthesis

Sulfadoxine synthesis: U.S. Patent 3,132,139 BE 618639 ^[5]^[6]

References

^ Medical Treatment - Sulphadoxine and Pyrimethamine.
^ Matondo SI, Temba GS, Kavishe AA et al. (2014). "High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.". Malar J 13: 152. doi:10.1186/1475-2875-13-152. PMC 3998221. PMID 24751352.
^ http://en.scientificcommons.org/19483411.
^ "WHO Model List of EssentialMedicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.
^ Bretschneider, H.; Richter, W.; Kl�Tzer, W. (1965). "Synthesen des 4-Sulfanilamido-5,6-dimethoxypyrimidins". Monatshefte f�r Chemie 96 (6): 1661. doi:10.1007/BF01185885. edit
^ Gr�Ssner, A.; Montavon, M.; Schnider, O. (1965). "Disubstituierte 4-Sulfanilamido-pyrimidine". Monatshefte f�r Chemie 96 (6): 1677. doi:10.1007/BF01185886. edit

This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 抗マラリア剤：概要 antimalarial drugs an overview
2. HIVとマラリア hiv and malaria
3. 合併症のない熱帯熱マラリアの治療 treatment of uncomplicated falciparum malaria
4. 妊娠中のマラリアの予防および治療 prevention and treatment of malaria in pregnant women
5. グローバー病（一過性および持続性棘融解性皮膚症） grovers disease transient and persistent acantholytic dermatosis

English Journal

Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.

Kar NP1, Chauhan K1, Nanda N1, Kumar A2, Carlton JM3, Das A4.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.Infect Genet Evol.2016 Jul;41:47-55. doi: 10.1016/j.meegid.2016.03.014. Epub 2016 Mar 15.
Considering malaria as a local and focal disease, epidemiological understanding of different ecotypes of malaria can help in devising novel control measures. One of the major hurdles in malaria control lies on the evolution and dispersal of the drug-resistant malaria parasite, Plasmodium falciparum.
PMID 26988711

Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.

Kaingona-Daniel EP1,2,3,4, Gomes LR1,2,4, Gama BE1,5, Almeida-de-Oliveira NK1,2,4, Fortes F6,4, Ménard D7, Daniel-Ribeiro CT1,2,4, Ferreira-da-Cruz MF8,9,10.
Malaria journal.Malar J.2016 Jun 7;15(1):309.
BACKGROUND: Malaria is a major parasitic disease, affecting millions of people in endemic areas. Plasmodium falciparum parasites are responsible for the most severe cases and its resistance to anti-malarial drugs is notorious. This is a possible obstacle to the effectiveness of intermittent preventi
PMID 27267365

Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.

Bouyou-Akotet MK1, Mawili-Mboumba DP2, Kendjo E3, Moutandou Chiesa S4, Tshibola Mbuyi ML3, Tsoumbou-Bakana G5, Zong J5, Ambounda N6, Kombila M2.
Transactions of the Royal Society of Tropical Medicine and Hygiene.Trans R Soc Trop Med Hyg.2016 Jun 6. [Epub ahead of print]
BACKGROUND: Six years after the implementation of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) in Gabon, its impact on placental malaria and pregnancy outcomes remains unknown.METHODS: Age, gestational data, use of IPTp-SP and birth weight were recorded d
PMID 27268713

Japanese Journal

Impact of Artemisinin-Based Combination Therapy on Falciparum Malaria in Urban Kolkata: A Clinic-Based Report

Saha Pabitra,Ganguly Swagata,Dutta Soma,Kundu Pratip K.,Bera Dilip K.,Basu Nandita,Maji Ardhendu K.
Japanese Journal of Infectious Diseases 68(4), 321-323, 2015
… specifically artesunate + sulfadoxine-pyrimethamine) has been implemented for uncomplicated falciparum malaria since 2010. …
NAID 130005088794

Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial

Scott Susana,Mens Petra F,Tinto Halidou,Nahum Alain,Ruizendaal Esmée,Pagnoni Franco,Peeters Grietens Koen,Kendall Lindsay,Bojang Kalifa,Schallig Henk,D'Alessandro Umberto
Trials 15, 340, 2014-08-28
… The secondary objectives are to determine the protective efficacy of CSST on maternal anaemia, maternal peripheral infection, low birth weight, selection of sulfadoxine-pyrimethamine (SP) resistance markers, and on antenatal clinic (ANC) attendance and coverage of intermittent preventive treatment during pregnancy (IPTp-SP).Methods/design: This is a multi-centre cluster-randomised controlled trial involving three countries with varying malaria endemicity; …
NAID 120005477056

重症先天性トキソプラズマ症の1例

瀬戸上貴資,太田栄治,合志光史 [他],廣瀬伸一
福岡大学医学紀要 39(3/4), 257-261, 2012-12
NAID 110009494828

Related Pictures

Sulfadoxine - Sulfadoxine Manufacturer, Supplier & Exporter Prevention of Malaria in Pregnancy | Using Community Directed Intervention Model to Comprimés de sulfadoxine + pyriméthamine- | AdvaCare Pharma Sulfadoxine-Pyrimethamine 500mg-25mg – Order & Save $64.72 Sulfadoxine Pyrimethamine:Ipca Laboratories Ltd: | ACTwatch Pyrimethamine/Sulfadoxine - patient information, description, dosage and directions. ARTECOSPE®Artesunate Tablets + Sulfadoxine/pyrimethamine Tablets - Guilin Sulfadoxine Et Pyrimethamine USP - Sulfadoxine Et Pyrimethamine USP Exporter

★リンクテーブル★

拡張検索	「pyrimethamine-sulfadoxine」

「pyrimethamine-sulfadoxine」

Sulfadoxine
Systematic (IUPAC) name
	4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Registry Number	2447-57-6
ATCvet code	QJ01EQ13
PubChem	CID: 17134
DrugBank	DB01299
ChemSpider	16218
UNII	88463U4SM5
KEGG	D00580
ChEMBL	CHEMBL1539
NIAID ChemDB	007816
Chemical data
Formula	C12H14N4O4S
Molecular mass	310.33 g/mol
	SMILES COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N;
(what is this?) (verify)

　　[★]

スルファドキシン・ピリメタミン合剤

関: pyrimethamine

pyrimethamine、sulfadoxine

[autogenerated1-1] Medical Treatment - Sulphadoxine and Pyrimethamine.

[2] Matondo SI, Temba GS, Kavishe AA et al. (2014). "High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.". Malar J 13: 152. doi:10.1186/1475-2875-13-152. PMC 3998221. PMID 24751352.

[3] ttp://en.scientificcommons.org/19483411.

[4] "WHO Model List of EssentialMedicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.

[5] Bretschneider, H.; Richter, W.; Kl�Tzer, W. (1965). "Synthesen des 4-Sulfanilamido-5,6-dimethoxypyrimidins". Monatshefte f�r Chemie 96 (6): 1661. doi:10.1007/BF01185885. edit

[6] Gr�Ssner, A.; Montavon, M.; Schnider, O. (1965). "Disubstituierte 4-Sulfanilamido-pyrimidine". Monatshefte f�r Chemie 96 (6): 1677. doi:10.1007/BF01185886. edit

匿名

検索

案内

案内

sulfadoxine